<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="8327">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02030704</url>
  </required_header>
  <id_info>
    <org_study_id>HDCCTA01</org_study_id>
    <nct_id>NCT02030704</nct_id>
  </id_info>
  <brief_title>CCTA-based Coronary Plaque Characterization and High-sensitive Troponin T for the Prediction of Cardiovascular Outcomes</brief_title>
  <official_title>Comprehensive 'Bio-Imaging' Using Quantitative Coronary Plaque Composition Assessment and the High-sensitive Troponin T for the Prediction of Cardiac Outcomes.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Heidelberg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>MTA‐SE Lendület Cardiovascular Imaging Research Group, Heart and Vascular Center, Semmelweis University, Budapest, Hungary.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Heidelberg, Institute of Psychology, Heidelberg, Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Heidelberg</source>
  <oversight_info>
    <authority>Germany: Ethics Commission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine the ability of semi‐automated plaque assessment in cardiac computed tomography
      angiography (CCTA) and high sensitive troponin T (hsTnT) for the risk stratification of
      patients at intermediate risk for coronary artery disease (CAD).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2008</start_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Cardiac death</measure>
    <time_frame>two years</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Nonfatal myocardial infarction</measure>
    <time_frame>two years</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Myocardial revascularization including PCI and CABG</measure>
    <time_frame>two years</time_frame>
    <safety_issue>No</safety_issue>
    <description>PCI  -  Percutaneous Coronary Intervention CABG  -  Coronary Artery Bypass Grafting</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">900</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>Noninvasive Plaque Characterization</condition>
  <arm_group>
    <arm_group_label>Atherosclerotic Plaque</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Consecutive patients scheduled to undergo CCTA
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical indication for CCTA according to the current appropriate use criteria

        Exclusion Criteria:

          -  non‐sinus rhythm

          -  acute coronary syndromes

          -  cardiomyopathies

          -  moderate or severe valvular disease

          -  elevated serum creatinine (&gt;1.5 mg/dl)

          -  history or ECG signs of previous myocardial infarction

          -  severe iodine allergy.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Grigorios Korosoglou, Prof. Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Heidelberg, Department of Cardiology, Heidelberg, Germany.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gitsios Gitsioudis, Dr. med.</last_name>
    <phone>+49(0)62215636621</phone>
    <email>gitsiosg@web.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Grigorios Korosoglou, Prof. Dr. med.</last_name>
    <phone>+49(0)62215637764</phone>
    <email>grigorios.korosoglou@med.uni-heidelberg.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Heidelberg, Department of Cardiology</name>
      <address>
        <city>Heidelberg</city>
        <state>Baden-Wuerttemberg</state>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gitsios Gitsioudis, Dr. med.</last_name>
      <phone>+49(0)62215636621</phone>
      <email>gitsiosg@web.de</email>
    </contact>
    <contact_backup>
      <last_name>Grigorios Korosoglou, Prof. Dr. med.</last_name>
      <phone>+49(0)62215637764</phone>
      <email>grigorios.korosoglou@med.uni-heidelberg.de</email>
    </contact_backup>
    <investigator>
      <last_name>Grigorios Korosoglou, Prof. Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>MTA‐SE Lendület Cardiovascular Imaging Research Group, Heart and Vascular Center, Semmelweis University</name>
      <address>
        <city>Budapest</city>
        <zip>1122</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pál Maurovich‐Horvat, Prof. Dr.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Hungary</country>
  </location_countries>
  <reference>
    <citation>Korosoglou G, Mueller D, Lehrke S, Steen H, Hosch W, Heye T, Kauczor HU, Giannitsis E, Katus HA. Quantitative assessment of stenosis severity and atherosclerotic plaque composition using 256-slice computed tomography. Eur Radiol. 2010 Aug;20(8):1841-50. doi: 10.1007/s00330-010-1753-3. Epub 2010 Mar 20.</citation>
    <PMID>20306078</PMID>
  </reference>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 7, 2014</lastchanged_date>
  <firstreceived_date>January 7, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Heidelberg</investigator_affiliation>
    <investigator_full_name>GKorosoglou</investigator_full_name>
    <investigator_title>Prof. Dr. med.</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
